Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

Share on Pinterest Zepbound is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 ... pen, also called a Zepbound pen. The vial doses available are 2.5 mg ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

as well as cardiovascular and kidney death with a 1 mg/kg weekly dose of the injectable drug compared to placebo. That is the same dose of the drug used in the formulation of Ozempic used for the ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

Samsung has since clarified that Bluetooth support for the S Pen is, in fact, gone. According to Samsung, the blog post was made in error, and the Galaxy S25 Ultra will not offer any Bluetooth ...

GLP-1 agonist medications ... dose of 2.0 mg weekly. Common side effects include nausea, vomiting, diarrhea, and constipation. Consult your healthcare provider or the Ozempic medication guide ...

The trial revealed that Ozempic® 1 mg significantly lowered the relative risk of worsening kidney disease, kidney failure, and cardiovascular death by 24% compared to a placebo, in addition to ...